At TD2, we are revolutionizing oncology research through an integrated ecosystem that brings together preclinical services, advanced flow cytometry, robust regulatory support, an extensive …

Choosing TD2 means selecting a dedicated partner that combines scientific rigor with strategic vision. Our comprehensive oncology ecosystem and collaborative approach ensure your drug …

TD2 Oncology accelerates preclinical drug development with a robust suite of in vivo and in vitro tumor model systems and advanced bioanalytical services, designed to generate clinically …

In the 4.5 years I have worked at TD2, I have been very impressed with the continued growth of the company. This is due in large part to the outstanding leadership team as well as the highly …

Jun 4, 2020 · The acquisition of TD2 by RCT will be a catalyst to expand and accelerate TD2’s platform of integrated oncology solutions and to position TD2 as the leader in strategic …

Jul 29, 2025 · The partnership combines TD2’s proven oncology execution capabilities with Curadh’s deep scientific innovation in the radiopharmaceutical space, accelerating the …

HAVE A QUESTION? Contact Our Experts GET STARTED Ask us how you can get your oncology medicine to market faster with TD2. Get Started Now

At TD2 Oncology, we provide comprehensive clinical research solutions tailored specifically for oncology. From trial design and feasibility through site management, data analysis, and final …

Sep 4, 2024 · TD2 continues to be a trusted partner in the pharmaceutical and biotech industry, offering a wide range of services, including preclinical and clinical trial management, …

TD2 is attending AACR 2024 and presenting three posters. The posters feature new research around glioblastoma PDX models, flow cytometry evaluation of cell cycle arrest, and …